ONCOTICE poudre pour suspension intravésicale 1 pc

7680525630383 CH-52563 L03AX03 07.16.1.
ONCOTICE poudre pour suspension intravésicale 1 pc
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5256301
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: bacillus Calmette-Guérin (BCG) vivus attenuatum (TICE) 200 - 800 Million CFU, lactosum monohydricum, asparaginum monohydricum, acidum citricum monohydricum, dikalii phosphas anhydricus, magnesii sulfas heptahydricus, ammonii ferri citras, glycerolum, ammonii hydroxidum, zinci formicas, pro vitro.

Articles (1)

OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/01/2026
Professional SmPC
Français
29/01/2026
Professional SmPC
Italien
29/01/2026

Detailed composition

Substance Quantity Type Category
bacillus Calmette-Guérin (BCG) vivus attenuatum (TICE)
- Substance Wirkstoff (Principe actif)
lactosum monohydricum
- Substance HNIDK
asparaginum monohydricum
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
magnesii sulfas heptahydricus
- Substance HNIDK
ammonii ferri citras
- Substance HNIDK
glycerolum
- Substance HNIDK
ammonii hydroxidum
- Substance HNIDK
zinci formicas
- Substance HNIDK

Reimbursement information

Public price
CHF 122.50
Specialties list
Yes
Generic
No
SL addition date: 15/03/1997

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
52563
Drug name
OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung
Galenic form
PULVIV
ATC Code
L03AX03
Authorization status
Z
Dispensation category
A
First authorization
16/11/1994
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
BCG-Immunotherapeutikum zur Behandlung des In-situ-Karzinoms der Harnblase

Packaging details

Description (FR)
ONCOTICE poudre pour suspension intravésicale 1 pc
Description (DE)
ONCOTICE Pulver zur Herstellung einer Suspensionen
Market launch
16/11/1994
Narcotic (BTM)
No
Buy us a coffee Explore the data